- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... **Main Responsibilities & Accountabilities** -Define and maintain clinical development and operations standards, including protocol templates, CRFs, operational… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... **The Opportunity:** Reporting to the Senior Director, Portfolio & Development Finance, as the **Senior Analyst, Portfolio & ...for changes that support the R&D organization in Finance process improvement activities You will also: + Support the… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... lead statistical components of statistical contribution to a clinical development program. The Principal Biostatistician implements the statistical strategies for… more
- CSL Behring (King Of Prussia, PA)
- …by three core scientific platforms: plasma fractionation, recombinant protein technology, and cell and gene therapy -helping address unmet medical needs and ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- …by three core scientific platforms: plasma fractionation, recombinant protein technology, and cell and gene therapy -helping address unmet medical needs and ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- …by three core scientific platforms: plasma fractionation, recombinant protein technology, and cell and gene therapy -helping address unmet medical needs and ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... execute all aspects of epidemiology research programs/studies, including protocol development , data collection, data management, data analysis, report generation,… more
- CSL Behring (King Of Prussia, PA)
- …+ Responsible for obtaining medical/regulatory/legal guidance as needed in materials or program development process to ensure alignment early in process . ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... Disease Area Lead for the US, this leader will drive both the professional development of the MSL team and the effective execution of medical affairs priorities.… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... be presented with an exciting opportunity to broaden your development horizons in an area of strategic importance to...will establish a deep understanding of the Clinical Trial process at CSL to effectively model costing for the… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... Biostatistics, leads the full scope of statistical contribution to a clinical development program. The AD provides statistical strategies for the clinical trials and… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... is onsite three days a week. You will be a critical role within Clinical Development . You are accountable for the design and execution of the clinical strategy to… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... of CSL Behring products and for managing all aspects of territory business development . Area Manager will cultivate and maintain relationships with key customers to… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... + Direct Reports: None Key Responsibilities 1. Contract Execution + Lead the development and negotiation of contracts to support market access. + Manage the full… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... targets and expense objectives while adhering to CSL Behring Core Values. Development of sales representatives through effective coaching. Works closely with the… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... + Serve as primary business partner and strategic advisor to SVP, Portfolio Development , SVP, GRAS and VP, Portfolio and Operations Excellence to shape and… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... processes. + Provide regulatory leadership and guidance to marketing during development , review, and approval of promotional materials for assigned therapeutic… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... the key Global Logistics & Warehousing Category and will be responsible for the development and execution across CSL Behring, CSL Vifor and CSL Seqirus (the entire… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... to CSL products. The individual will collaborate across functions in the development of customer specific needs delivered by a field-based reimbursement manager… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... & Capability Building and other interface functions to identify opportunities of process improvement. . Lead role in liaising with Health Authorities where… more
